Furo[3,2-d]pyrimidine compounds
US8551981B2 · kind B2 · utility
2Cited by
2References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 7, 2011 |
| Grant date | Oct 8, 2013 |
| Priority date | — |
| Expiry date | Oct 7, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to novel compounds of Formula (I)pharmaceutically acceptable salts, biologically active metabolites, pro-drugs, racemates, enantiomers, diastereomers, solvates and hydrates thereof wherein the variables are defined as herein. The compounds of Formula (I) are useful as kinase inhibitors and as such would be useful in treating certain conditions and diseases, especially inflammatory conditions and diseases and proliferative disorders and conditions, for example, cancers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.